Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

Compare
0.475
+0.010
+(2.15%)
At close: April 3 at 4:08:14 PM GMT+8
Loading Chart for 8189.HK
  • Previous Close 0.465
  • Open 0.465
  • Bid 0.450 x --
  • Ask 0.470 x --
  • Day's Range 0.450 - 0.475
  • 52 Week Range 0.065 - 0.650
  • Volume 1,515,000
  • Avg. Volume 3,648,277
  • Market Cap (intraday) 964.678M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -0.000
  • Earnings Date Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates through two segments, Biological Compound Fertilisers Products, and Elderly Care and Health Care Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; elderly equipment leasing services; and elderly care consulting, advisory, management, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation research services; trading of wine and specializing in system platform development; and provision of soil environmental quality standards research services, as well as information transmission, software, and information technology service industry. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.

bioteda.com

260

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 8189.HK

View More

Performance Overview: 8189.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

8189.HK
46.15%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

8189.HK
416.30%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

8189.HK
189.63%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

8189.HK
439.77%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 8189.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8189.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    964.68M

  • Enterprise Value

    1.06B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.98

  • Price/Book (mrq)

    19.67

  • Enterprise Value/Revenue

    2.35

  • Enterprise Value/EBITDA

    445.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.21%

  • Return on Assets (ttm)

    -5.58%

  • Return on Equity (ttm)

    -81.67%

  • Revenue (ttm)

    385.48M

  • Net Income Avi to Common (ttm)

    -29.65M

  • Diluted EPS (ttm)

    -0.000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.4M

  • Total Debt/Equity (mrq)

    562.29%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8189.HK

View More

Company Insights: 8189.HK

Research Reports: 8189.HK

View More

People Also Watch